This product is a recombinant Alpaca antibody that can recognize VSV N. VHH 1307 competes with the polymerase cofactor P for binding and thus inhibits replication and mRNA transcription.
Figure 1 VHH binding to N and the N/P complex.
Biotinylated, N-specific VHHs, and a control VHH (aNP-VHH1, influenza A nucleoprotein specific) were immobilized on streptavidin beads and N alone, or N in complex with P was added to the beads. Bound protein was eluted and subjected to 10% SDS–PAGE (75:1 acrylamide/bis-acrylamide) and Coomassie staining. A representative gel from three independent experiments is shown.
Hanke, L., Schmidt, F. I., Knockenhauer, K. E., Morin, B., Whelan, S. P., Schwartz, T. U., & Ploegh, H. L. (2017). Vesicular stomatitis virus N protein‐specific single‐domain antibody fragments inhibit replication. EMBO reports, 18(6), 1027-1037.
Figure 2 Inhibitory properties of VSV N‐specific VHHs
VSV N-specific VHHs differentially cope with increasing doses of VSV. A549 cells expressing VHHs in a doxycycline (Dox)‐inducible manner were seeded 24 h before VSV infection. VHH expression was induced (gray to black bars) with Dox, or cells were left untreated (white bars). Each cell line was infected with increasing amounts of VSV‐GFP (MOI = 0–320).
Hanke, L., Schmidt, F. I., Knockenhauer, K. E., Morin, B., Whelan, S. P., Schwartz, T. U., & Ploegh, H. L. (2017). Vesicular stomatitis virus N protein‐specific single‐domain antibody fragments inhibit replication. EMBO reports, 18(6), 1027-1037.
Figure 3 Inhibitory properties of VSV N‐specific VHHs
Quantification of VHH expression levels in A549 cells. Cells were seeded, and HA‐tagged VHH expression was induced with Dox.
Hanke, L., Schmidt, F. I., Knockenhauer, K. E., Morin, B., Whelan, S. P., Schwartz, T. U., & Ploegh, H. L. (2017). Vesicular stomatitis virus N protein‐specific single‐domain antibody fragments inhibit replication. EMBO reports, 18(6), 1027-1037.
Figure 4 VHH binding to N and the N/P complex.
Biotinylated, N-specific VHHs, and a control VHH (αNP‐VHH1, influenza A nucleoprotein specific) were immobilized on streptavidin beads and N alone, or N in complex with P was added to the beads.
Hanke, L., Schmidt, F. I., Knockenhauer, K. E., Morin, B., Whelan, S. P., Schwartz, T. U., & Ploegh, H. L. (2017). Vesicular stomatitis virus N protein‐specific single‐domain antibody fragments inhibit replication. EMBO reports, 18(6), 1027-1037.
Figure 5 Band intensities of the immunoprecipitated N and coimmunoprecipitated P were quantified, and the relative amount of P compared to N is displayed.
Band intensities of the immunoprecipitated N and coimmunoprecipitated P were quantified, and the relative amount of P compared to N is displayed.
Hanke, L., Schmidt, F. I., Knockenhauer, K. E., Morin, B., Whelan, S. P., Schwartz, T. U., & Ploegh, H. L. (2017). Vesicular stomatitis virus N protein‐specific single‐domain antibody fragments inhibit replication. EMBO reports, 18(6), 1027-1037.
Figure 6 VHH binding to VSV N escape variants
Indicated, HA-tagged VHHs and VSV N (WT or mutated versions) fused to Renilla luciferase, or influenza A NP fused to Renilla luciferase were transiently coexpressed in 293T cells. 96-well plates coated with anti-HA antibody to capture the VHHs were incubated with cell lysates. Activity of the copurified luciferase was measured. Emitted light was normalized to luciferase activity in the lysate.
Hanke, L., Schmidt, F. I., Knockenhauer, K. E., Morin, B., Whelan, S. P., Schwartz, T. U., & Ploegh, H. L. (2017). Vesicular stomatitis virus N protein‐specific single‐domain antibody fragments inhibit replication. EMBO reports, 18(6), 1027-1037.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
PABC-565 | Recombinant Alpaca Anti-VSV N Single Domain Antibody (PABC-565) | FC, IP, Inhib | Alpaca VHH |
There are currently no Customer reviews or questions for PABC-564. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.